Published :
Tables : 60
Figures : 36
Category : Healthcare
No. of Pages : 200
Report Code : HC-1267
Auto Injectors Market Introduction: Auto Injectors Market is projected to value over USD 7 billion by 2027 end and register a CAGR of over 20.1% during the forecast period 2020 to 2027. Auto injector is a medical device that is used for dispensing a single drug dose, life-saving drugs in particular. These auto injectors are generally syringes that are spring-loaded and are peculiarly designed for safe and easy drug administration. The method of injectable drug delivery is a market-driven on technology and it has experienced an exemplar shift in recent years. Currently, the conventionally used devices for self-injection, which were rarely used for insulin and human growth hormone delivery are replaced by advanced auto injectors. Auto injectors have experienced a significant adoption owing to the benefits provided over traditional devices like prototype syringes for drug delivery to parents. The risks related to the traditional syringes are a risk of drug discontinuity and missed injection. These risks are eliminated by auto injectors and the overall cost of healthcare is also reduced as the number of hospital visits are curbed down eventually. Therefore, auto injectors have assured better patient adherence for treating multiple diseases. Various auto injector alternatives are available which would help the market grow substantially to meet the needs of stimulating innovation, especially in therapeutic areas. The surge of biologics for drug delivery, improvements in the compliance of patients, simplification of self-administration and increasing prevalence of cancer and diabetes are the important factors that stimulate the global auto injectors market growth. Nonetheless, regulatory obstacles, injuries and needle-stick infections impede the market growth. The global auto injector market is fragmented based on design, technology, product type, application, geography and type. On the basis of the type of product, the market is bifurcated into prefilled and fillable auto injectors. Based on technology, the market is bifurcated into automated and manual auto injectors. On the basis of type, the auto injectors market is segmented into reusable and disposable auto injectors. The auto injector market, based on design is categorized into customized and standardized. There are multiple applications of these devices for treating diseases like anaphylaxis, rheumatoid arthritis, multiple sclerosis and others. Regionally, the report is fragmented into four regions, Europe, North America, Latin America and the Middle East & Africa and the Asia-Pacific. Key market players included in the global auto injectors market industry are Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton, Dickinson and Co., Owen Mumford, Consort Medical, Haselmeir, Shl Group, Johnson & Johnson, Teva, Antares Pharma, Sanofi and Pfizer, Inc. Auto Injectors Market Segmentation: By Therapy Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies By Type • Disposable Auto Injectors • Reusable Auto Injectors o Prefilled Auto Injectors o Empty Auto Injectors By End User Home Care Settings Hospitals & Clinics By Region North America Europe Asia Pacific Rest of the World FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global auto injectors market by therapy, by type, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Auto Injectors Market is projected to value over USD 7 billion by 2027 end and register a CAGR of over 20.1% during the forecast period 2020 to 2027.
Auto injector is a medical device that is used for dispensing a single drug dose, life-saving drugs in particular. These auto injectors are generally syringes that are spring-loaded and are peculiarly designed for safe and easy drug administration. The method of injectable drug delivery is a market-driven on technology and it has experienced an exemplar shift in recent years. Currently, the conventionally used devices for self-injection, which were rarely used for insulin and human growth hormone delivery are replaced by advanced auto injectors.
Auto injectors have experienced a significant adoption owing to the benefits provided over traditional devices like prototype syringes for drug delivery to parents. The risks related to the traditional syringes are a risk of drug discontinuity and missed injection. These risks are eliminated by auto injectors and the overall cost of healthcare is also reduced as the number of hospital visits are curbed down eventually.
Therefore, auto injectors have assured better patient adherence for treating multiple diseases. Various auto injector alternatives are available which would help the market grow substantially to meet the needs of stimulating innovation, especially in therapeutic areas. The surge of biologics for drug delivery, improvements in the compliance of patients, simplification of self-administration and increasing prevalence of cancer and diabetes are the important factors that stimulate the global auto injectors market growth. Nonetheless, regulatory obstacles, injuries and needle-stick infections impede the market growth.
The global auto injector market is fragmented based on design, technology, product type, application, geography and type. On the basis of the type of product, the market is bifurcated into prefilled and fillable auto injectors. Based on technology, the market is bifurcated into automated and manual auto injectors. On the basis of type, the auto injectors market is segmented into reusable and disposable auto injectors. The auto injector market, based on design is categorized into customized and standardized. There are multiple applications of these devices for treating diseases like anaphylaxis, rheumatoid arthritis, multiple sclerosis and others. Regionally, the report is fragmented into four regions, Europe, North America, Latin America and the Middle East & Africa and the Asia-Pacific.
Key market players included in the global auto injectors market industry are Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton, Dickinson and Co., Owen Mumford, Consort Medical, Haselmeir, Shl Group, Johnson & Johnson, Teva, Antares Pharma, Sanofi and Pfizer, Inc.
Auto Injectors Market Segmentation:
By Therapy
By Type
• Disposable Auto Injectors • Reusable Auto Injectors o Prefilled Auto Injectors o Empty Auto Injectors
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Auto Injectors Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global Auto Injectors Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Auto Injectors Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Auto Injectors Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Auto Injectors Market, By Therapy Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Rheumatoid Arthritis 7.2. Multiple Sclerosis 7.3. Diabetes 7.4. Anaphylaxis 7.5. Other Therapies 8. Global Auto Injectors Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Disposable Auto Injectors 8.2. Reusable Auto Injectors 8.2.1. Prefilled Auto Injectors 8.2.2. Empty Auto Injectors 9. Global Auto Injectors Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Home Care Settings 9.2. Hospitals & Clinics 10. North America Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Abbvie 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Mylan 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. ELI Lilly 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Ypsomed 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Amgen 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Becton Dickinson and Co. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Owen Mumford 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Consort Medical 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Haselmeir 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Shl Group 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Johnson & Johnson 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Teva 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Antares Pharma 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Sanofi 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. Pfizer, Inc. 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Auto Injectors Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards And Compliances
5. Global Auto Injectors Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus of Auto Injectors Companies on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Auto Injectors Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Auto Injectors Market, By Therapy Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Rheumatoid Arthritis
7.2. Multiple Sclerosis
7.3. Diabetes
7.4. Anaphylaxis
7.5. Other Therapies
8. Global Auto Injectors Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Disposable Auto Injectors
8.2. Reusable Auto Injectors
8.2.1. Prefilled Auto Injectors
8.2.2. Empty Auto Injectors
9. Global Auto Injectors Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Home Care Settings
9.2. Hospitals & Clinics
10. North America Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.2.1. U.S.A
10.2.2. Canada
10.2.3. Mexico
10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Latin America Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.3.1. Brazil
11.3.2. Venezuela
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Market Size (USD Million) Forecast for Latin America 2020-2027
12. Europe Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Germany
12.2.2. U.K
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Russia
12.2.7. Poland
12.2.8. Switzerland
12.2.9. Rest of Western Europe
12.3. Market Size (USD Million) Forecast for Europe 2020-2027
13. Asia Pacific Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Japan
13.2.2. China
13.2.3. Singapore
13.2.4. India
13.2.5. Australia and New Zealand
13.2.6. ASEAN
13.2.7. South Korea
13.2.8. Taiwan
13.2.9. Rest of Asia Pacific
13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Auto Injectors Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Saudi Arabia
14.2.2. UAE
14.2.3. South Africa
14.2.4. Egypt
14.3. Market Size (USD Million) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
15.1. Abbvie
15.1.1. Company Overview
15.1.2. Product Portfolio
15.1.3. SWOT Analysis
15.1.4. Financial Overview
15.1.5. Strategic Overview
15.2. Mylan
15.2.1. Company Overview
15.2.2. Product Portfolio
15.2.3. SWOT Analysis
15.2.4. Financial Overview
15.2.5. Strategic Overview
15.3. ELI Lilly
15.3.1. Company Overview
15.3.2. Product Portfolio
15.3.3. SWOT Analysis
15.3.4. Financial Overview
15.3.5. Strategic Overview
15.4. Ypsomed
15.4.1. Company Overview
15.4.2. Product Portfolio
15.4.3. SWOT Analysis
15.4.4. Financial Overview
15.4.5. Strategic Overview
15.5 Amgen
15.5.1. Company Overview
15.5.2. Product Portfolio
15.5.3. SWOT Analysis
15.5.4. Financial Overview
15.5.5. Strategic Overview
15.6 Becton Dickinson and Co.
15.6.1. Company Overview
15.6.2. Product Portfolio
15.6.3. SWOT Analysis
15.6.4. Financial Overview
15.6.5. Strategic Overview
15.7. Owen Mumford
15.7.1. Company Overview
15.7.2. Product Portfolio
15.7.3. SWOT Analysis
15.7.4. Financial Overview
15.7.5. Strategic Overview
15.8. Consort Medical
15.8.1. Company Overview
15.8.2. Product Portfolio
15.8.3. SWOT Analysis
15.8.4. Financial Overview
15.8.5. Strategic Overview
15.9. Haselmeir
15.9.1. Company Overview
15.9.2. Product Portfolio
15.9.3. SWOT Analysis
15.9.4. Financial Overview
15.9.5. Strategic Overview
15.10. Shl Group
15.10.1. Company Overview
15.10.2. Product Portfolio
15.10.3. SWOT Analysis
15.10.4. Financial Overview
15.10.5. Strategic Overview
15.11. Johnson & Johnson
15.11.1. Company Overview
15.11.2. Product Portfolio
15.11.3. SWOT Analysis
15.11.4. Financial Overview
15.11.5. Strategic Overview
15.12. Teva
15.12.1. Company Overview
15.12.2. Product Portfolio
15.12.3. SWOT Analysis
15.12.4. Financial Overview
15.12.5. Strategic Overview
15.13. Antares Pharma
15.13.1. Company Overview
15.13.2. Product Portfolio
15.13.3. SWOT Analysis
15.13.4. Financial Overview
15.13.5. Strategic Overview
15.14. Sanofi
15.14.1. Company Overview
15.14.2. Product Portfolio
15.14.3. SWOT Analysis
15.14.4. Financial Overview
15.14.5. Strategic Overview
15.15. Pfizer, Inc.
15.15.1. Company Overview
15.15.2. Product Portfolio
15.15.3. SWOT Analysis
15.15.4. Financial Overview
15.15.5. Strategic Overview
16. Impact of COVID-19
16.1. Positive influence on the healthcare industry
16.2. The financial disruption of the manufacturing sector
16.3. Impact of COVID-19 on emerging companies
16.4. Significant mandates in the healthcare regulations initiated by administrations
16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics